Clinical Trial: A single-arm, exploratory clinical study of Dalpiciclib combined with letrozole in the preoperative treatment of HR-positive, HER2-negative early or locally advanced breast cancer and the exploration of key factors for prognostic evaluation (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, exploratory clinical study of Dalpiciclib combined with letrozole in the preoperative treatment of HR-positive, HER2-negative early or locally advanced breast cancer and the exploration of key factors for prognostic evaluation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131806

Registration Time: 2026/09/07

Type: Interventional study

Primary Sponsor: Weifang People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=285733

Published by HT Digital Content Services with permission from Health Daily Digest....